SQSTM1 and neoplasm: Along with our previous data on anti-tumor and anti-metastatic activity of p62 DNA vaccine in allogeneic tumors in rodents and a comprehensive set of pre-clinical data, these results justify further clinical development of p62 DNA vaccine as a veterinary medicine and its advancement into human clinical trials.